Search

See All
Reset

*Schools currently available: Cummings School of Veterinary Medicine, School of Dental Medicine, School of Engineering, The Fletcher School of Law and Diplomacy, Friedman School of Nutrition Science and Policy, School of Medicine, and Graduate School of Biomedical Sciences.

141 - 150 of 178 Results
See All

Seed Layer Assisted Chemical Bath Deposition of CuO on ITO/glass Substrates with Tunable Crystalinity

Technology
Semiconductor oxides are a promising alternative to silicon-based solar cells because they possess high optical absorption and are composed of low cost materials. Cupric oxide (CuO) films have now
https://viceprovost.tufts.edu/seed-layer-assisted-chemical-bath-deposition-cuo-itoglass-substrates-tunable-crystalinity

PDMS-Supported Ionogels and a Method to Produce such Materials

Technology
Ionogels are hybrid materials based on ionic liquids (salts that are molten at room temperature) and a solid support material. Researchers at Tufts have now created a series of novel ionogels which
https://viceprovost.tufts.edu/pdms-supported-ionogels-and-method-produce-such-materials

A method for non-surgical sterilization of mammals using an antibody-guided nanoparticle carrying cytotoxin to kill gonadal cells exhibiting anti-Mullerian hormone II receptors

Technology
Non-surgical, species agnostic animal sterilizationResearchers at Tufts University have devised a novel, fast, and non-surgical means to induce apoptosis in animal gonads. Lipid‐like carriers are used
https://viceprovost.tufts.edu/method-non-surgical-sterilization-mammals-using-antibody-guided-nanoparticle-carrying-cytotoxin

Gal-8 Inhibition as a Treatment of Diseases associated with pathological Lymphangiogenesis

Technology
Targeting Galectin-8 to prevent lymphangiogenesisLead Inventor: Dr. Noorjahan PanjwaniTufts case T001991Bussiness Opportunity: Researchers at Tufts University have shown that Galectin-8 inhibitors
https://viceprovost.tufts.edu/gal-8-inhibition-treatment-diseases-associated-pathological-lymphangiogenesis

Stabilization of therapeutic peptides by non-perturbative chemical modification

Technology
Stabilization of therapeutic peptides by non-perturbative chemical modification US Publication No. 2019-0055279 (February 21, 2019) Licensing ContactJohn Cosmopoulosjohn.cosmopolous@tufts.edu
https://viceprovost.tufts.edu/stabilization-therapeutic-peptides-non-perturbative-chemical-modification

ELECTRONIC LARYNX

Technology
SUMMARYTufts University investigators have developed an improved artificial larynx that enables patients undergoing laryngectomies or tracheostomies to communicate with a level of expression and
https://viceprovost.tufts.edu/electronic-larynx

Intrinsically cell-penetrant, autophagy-inducing peptides

Technology
Tufts University investigator, Joshua Kritzer, has developed a family of modified peptides that induce the biological process of autophagy. These peptides are potential therapeutics for diseases in
https://viceprovost.tufts.edu/intrinsically-cell-penetrant-autophagy-inducing-peptides

Silk Water Lithography

Technology
SUMMARYTufts University investigators have developed a room temperature lithography technique that eliminates the need for expensive equipment and minimizes the use of harsh chemicals without
https://viceprovost.tufts.edu/silk-water-lithography

Multi-Threshold FinFET Design via Fin Shape Control

Technology
Lead Inventor: Soha HassounTufts University Case T001998Overview: Design technique for creating multi-threshold FinFET transistors via fin shape control.Technology: A process for modifying the doping
https://viceprovost.tufts.edu/multi-threshold-finfet-design-fin-shape-control

Highly Stereoselective Glycosylation Reactions

Technology
Researchers at Tufts University have developed a new method to generate 1,2-cis-a-glycosides without the need for specialized directing groups. The new synthetic approach uses thioglycoside donors
https://viceprovost.tufts.edu/highly-stereoselective-glycosylation-reactions